Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (720)

1

Efficacy and safety of trastuzumab deruxtecan in treating human epidermal growth factor receptor 2-low/positive advanced breast cancer:A meta-analysis of randomized controlled trials

enthalten in: Critical reviews in oncology/hematology | 2024

von Ma, R. | Shi, Y. | Yan, R. | +3

2

What Powers Trastuzumab's Cardiotoxicity? Decoding Mitochondrial-Related Gene Expression Through Integrative Review and Meta-Analysis in Cardiomyocytes

enthalten in: Omics : a journal of integrative biology | 2024

von Rodrigues, K. | Caetano, D. | Cavalcante, J. | +3

3

Lung toxicity induced by anti-HER2 antibody - drug conjugates for breast cancer

enthalten in: Critical reviews in oncology/hematology | 2024

von Chai, M. | Li, L. | Wu, H. | +3

4

Exploring DESTINY : the Past, Present, and Future of Trastuzumab Deruxtecan

enthalten in: Current oncology reports | 2024

von Ali, A. | Graff, S.

5

New approaches for human epidermal growth factor receptor 2-low and human epidermal growth factor receptor 2-overexpressing metastatic breast cancer

enthalten in: Current opinion in obstetrics & gynecology | 2024

von Britten, K. | McAndrew, N.

6

Toxic Cardiomyopathy in a Young Patient Treated for Her2-Positive Early Breast Cancer : Case Report and Literature Review

enthalten in: Acta medica academica | 2023

von Hadžibeganović, A. | Koprić, D.

7

New treatment options for metastatic HER2-low breast cancer : Consequences for histopathological diagnosis

enthalten in: Pathologie (Heidelberg, Germany) | 2023

von Denkert, C. | Lebeau, A. | Schildhaus, H. | +2

8

Trastuzumab Deruxtecan : A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma

enthalten in: Targeted oncology | 2023

von Kang, C.

9

Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer

enthalten in: Clinical breast cancer | 2023

von Graff, S. | Yan, F. | Abdou, Y.

10

Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers

enthalten in: International immunopharmacology | 2023

von Wu, X. | Huang, S. | He, W. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[72]